Jump to content

Pharmacopeia, Inc.

Add links
From Wikipedia, the free encyclopedia
(Redirected from Pharmacopeia biotechnology)

Pharmacopeia was a public biotechnology company that pioneered the field of small molecule combinatorial chemistry.

Pharmacopeia was founded by Larry Bock and Drs. Michael Wigler, Clark Still and Jack Chabala.

Pharmacopeia went public in 1996 and was acquired by Ligand Pharmaceuticals[1] on December 13, 2008.

References[edit]

  1. ^ Myers, Calisha (September 25, 2008). "Ligand Pharmaceuticals Inc. to Acquire Pharmacopeia, Inc. for Stock and Contingent Value Rights for $70M". Fierce Biotech.{{cite web}}: CS1 maint: url-status (link)

External links[edit]

    • Historical business data for Pharmacopeia, Inc.:
    • SEC filings
Retrieved from "https://en.wikipedia.org/w/index.php?title=Pharmacopeia,_Inc.&oldid=1228566894"